Filing Details

Accession Number:
0000784199-24-000154
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2024-03-14 20:36:32
Reporting Period:
2024-02-23
Accepted Time:
2024-03-14 20:36:32
Original Submission Date:
2024-02-28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
784199 Artivion Inc. AORT Surgical & Medical Instruments & Apparatus (3841) 592417093
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1849615 S. Marshall Stanton 1655 Roberts Blvd., Nw
Kennesaw GA 30144
Svp, Clinical & Md Affair No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-02-23 5,386 $0.00 74,089 No 4 A Direct
Common Stock Disposition 2024-02-26 1,576 $20.27 72,513 No 4 S Direct
Common Stock Acquisiton 2024-02-23 10,644 $0.00 83,157 No 4 A Direct
Common Stock Disposition 2024-02-26 1,431 $20.27 81,726 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
No 4 A Direct
No 4 S Direct
Footnotes
  1. Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024.
  2. These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 1,600 shares were sold, when in fact, 1,576 shares were sold.
  3. As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4.
  4. Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date.
  5. These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 1,448 shares were sold, when in fact, 1,431 shares were sold.